ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Rabbit Antithymocyte Globulin Is Associated With Improved Patient and Graft Survival in Liver Transplantation. Experience With 595 Patients

    M. Montenovo,1 F. Jalikis,2 L. Meng,3 Y. Matthew,2 D. Andre,1 H. Ryan,3 R. Jorge.1

  • Racial Differences in Transplant and Waitlist Mortality Rates Among HIV+ Kidney Transplant Candidates

    J. Locke,1 S. Gustafson,2 C. Durand,3 J. Snyder,2 B. Shelton,1 R. Reed,1 P. MacLennan,1 S. Mehta,1 A. Nellore,1 D. Segev.2,3

  • Racial Disparities in Access to Kidney Re-Transplantation in the United States

    C. Garrett, R. Patzer, R. Zhang, A. Adams.

  • Racial Disparities in Living Donor Liver Transplantation

    Y. Nobel,1 K. Forde,2 L. Wood,3 P. Yoo,4 P. Abt,3 D. Goldberg.2

  • Racial Disparities in Preemptive Kidney Transplant Referrals in Georgia: Data from the RaDIANT Community Study

    J. Gander,1 L. Plantinga,1 M. Basu,1 L. Sauls,2 S. Pastan,1 E. Gibney,3 L. Mulloy,4 R. Patzer.1

  • Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End Stage Renal Disease (ESRD) Patients: A Multi-Level Mixed Modeling Approach

    K. Newman,1 S. Fedewa,1 M. Jacobson,1 A. Adams,2 R. Zhang,2 R. Patzer.1,2

  • Rapid Effector Function of TEMRA CD8 T Cells in Healthy Volunteers and in Immune-Stimulated Patients Requires Sustained Glycolytic Switch

    M. Yap,1,3 G. Tilly,1,3 M. Giral,1,2 D.-A. Laplaud,1,2 S. Brouard,1,2 C. Pecqueur,4 N. Degauque.1,2

  • Rat dnIKK2-Treg Derived Exosomes Suppress T Cell Proliferation, Generate T Regulatory Cells and Prolong Kidney Allograft Survival

    S. Aiello, F. Rocchetta, N. Azzollini, S. Tomasoni, G. Remuzzi, M. Noris, A. Benigni.

  • Rat Forelimb Allotransplantation: A Novel Microsurgical Model for Optimized Functional Assessment After Reconstructive Transplantation

    B. Kern,1 S. Tuffaha,1 M. Khusheim,1 S. Xiang,1 G. Furtmueller,1 K. Sarhane,1 J. Park,2 A. Hoke,2 W. Lee,1 G. Brandacher.1

  • Rational Development of Alloantigen Specific Regulatory T Cell Therapy Requires Insight Into Longevity of Alloimmune Pathways

    J. Ali, M. Negus, E. Bolton, J. Bradley, G. Pettigrew.

  • Re-Evaluate the Transplant Renal Artery Stenosis After Renal Transplantation Based On New Unenhanced Magnetic Resonance Angiography By Using Spatial Labeling With Multiple Inversion Pulses

    J. Wen,1 L. Zhang,2 Y. Li,2 X. Li,1 Z. Zhang,1 J. Chen,1 D. Cheng,1 Z. Liu.1

  • Real-Time Measurements of Tissue Oxygen Microtension as a Marker of Bile Duct Viability in Liver Transplantation

    R. Ciria-bru, E. Navarro-Rodriguez, M. Sanchez-Frías, J. Medina-Fernandez, A. Gallardo-Herrera, M. Ayllon-Teran, S. Rufián-Peña, P. Lopez-Cillero, J. Briceño-Delgado.

  • Reasons for Match Offer Refusals and Efforts to Reduce Them in the OPTN/UNOS Kidney Paired Donation Pilot Program (KPDPP)

    R. Leishman,1 D. Stewart,1 A. Kucheryavaya,1 L. Robbins Callahan,1 T. Sandholm,2 M. Aeder.3

  • Reassessing Tubulitis and Interstitial Infiltrate: Creating a New Probabilistic Definition of TCMR

    P. Halloran, I. Salazar, M. Lopez, J. Chang.

  • Recipient IL-33 Promotes Type 1 Alloimmunity and Lethal Acute GVHD Following alloHCT

    B. Matta,1 D. Reichenbach,2 V. Schwarze,3 V. Tkachev,4 L. Mathews,1 Q. Liu,1 M. Warncke,5 J. Ferrara,4 R. Zeiser,3 B. Blazar,2 H. Turnquist.1

  • Recipient Immunity to Murine Cytomegalovirus Influences Natural Killer Cell Responses in Infected Renal Allografts

    M. Shimamura,1 M. Li,1 B. Chen,2 J. George.2

  • Recipient Myelomonocytic Cells With Activated Hypoxia-Inducible Factor Alleviate Ischemia-Reperfusion Injury in Mouse Heart Allografts

    A. Raissadati, M. Keränen, E. Rouvinen, R. Krebs, K. Lemström.

  • Reciprocal Relationship Between Cytomegalovirus Infection and Graft Rejection in Intestinal/Multivisceral Transplantation: Impact on Survival and Ideal Immunosuppression Protocol

    S. Nagai, R. Mangus, E. Anderson, K. Doan, B. Ekser, C. Kubal, J. Fridell, A. Tector.

  • Reconsideration of Age Limits for Pancreas Transplantation

    J. Scalea, H. Sollinger, R. Redfield, M. Rizzari, D. Kaufman, J. Odorico.

  • Recovery After Living Donor Laparoscopic Nephrectomy

    D. Larson, J. Wiseman, D. Berglund, C. Jacobs, C. Garvey, H. Ibrahim, A. Matas.

  • Recreational and Lifestyle Infection Risks in Transplant Recipients

    R. Avery,1 D. Ostrander,1 S. Shoham,1 S. Alp,2 N. Lu,1 C. Cave,1 E. Kraus,3 K. Marr.1

  • Recreational Marijuana Use Is Not Associated With Worse Kidney Allograft Outcomes

    G. Greenan, M. Anders, A. Leeser, J. Bromberg, S. Niederhaus.

  • Recurrence of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) Alone and TACE in Combination With Other Treatment Modalities

    J. Balogh, A. Islam, A. Saharia, H. Monsour, S. Gordon Burroughs, M. Weiner, A. Gaber, R. Ghobrial.

  • Recurrent Cytomegalovirus Infection After Solid Organ Transplant

    Y. Natori, A. Humar, S. Husain, C. Rotstein, D. Kumar.

  • Recurrent IgA Nephropathy in Kidney Transplant Recipients Receiving a Steroid Sparing Immunosuppression Protocol

    K. Koutroutsos,1 R. Charif,1 D. Goodall,1 C. Roufosse,2 J. Galliford,1 T. Cook,2 D. Taube,1 M. Loucaidou.1

  • Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus

    H. Tedesco-Silva,1 C. Felipe,1 A. Ferreira,1 M. Cristelli,1 T. Sandes- Freitas,1 N. Oliveira,1 W. Aguiar,2 G. Bassos,1 M. Franco,3 M. Gerbase- Lima,4 E. Campos,4 J. Medina-Pestana.1

  • Reduced Intensity Immunosuppression Protocol Lowers Drug Costs and May Decrease Incidences of BK Viremia and Readmissions After Kidney and Kidney/Pancreas Transplant

    M. Mariski,1 A. DeGolovine,2 W. Dar,2 J. Bynon,2 H. Adrogué,2 M. Hobeika.2

  • Reduced Urinary Uromodulin (UMOD)-Levels Are associated With Urinary Tract Infections (UTI) After Renal Transplantion

    K. Stahl, J. Beneke, H. Haller, W. Gwinner, M. Schiffer.

  • Reduction of Tacrolimus With Everolimus Addition in Maintenance Immunosuppression Improves Calcineurin Inhibitor-Induced Arteriolopathy in Kidney Allografts

    M. Miura,1 H. Higashiyama,1 Y. Fukasawa.2

  • Referral for Kidney Transplantation in Georgia: Data from the RaDIANT Community Study

    S. Pastan,1 J. Gander,1 L. Plantinga,1 L. Sauls,2 E. Gibney,3 L. Mulloy,4 J. Krisher,2 R. Patzer.1

  • Refinement of Non-Invasive Diagnostic Criteria to Differentiate Tumor from Bland Portal Vein Thrombosis Before Liver Transplant in Patients With Hepatocellular Carcinoma

    C. Sherman, S. Behr, J. Dodge, J. Roberts, F. Yao, N. Mehta.

  • Regional Efficiency in Deceased Donor Utilization for Kidney Transplantation

    K. Schnier,1 N. Turgeon.2

  • Regional Mismatch Between Liver Supply and Demand: An Argument for a More Open Market

    J. Lai, S. Sen, J. Dodge, H. Hayssen, J. Roberts.

  • Regional Variations: Liver Transplant Tourism Within the US

    C. Frenette,1 A. Harper,2 R. Schaffer,1 J. Fisher,1 A. Baquerizo,1 C. Marsh.1

  • Regulatory T Cells Expanded by Activated iNKT Cells Facilitate Migration of Donor Dendritic Cells Into the Recipient Thymus and Subsequent Establishment of Clonal Deletion

    T. Hirai,1 R. Shibahara,1 S. Miyairi,1 M. Ikemiyagi,1 K. Omoto,1 Y. Ishii,2 K. Tanabe.1

  • Regulatory Tolerance Across a Full MHC Barrier Is More Robust Than Tolerance Across a Class I MHC Disparity Alone

    M. Madariaga, S. Michel, G. La Muraglia II, M. O'Neil, W. Orent, V. Villani, M. Sekijima, E. Farkash, R. Colvin, J. Allan, K. Yamada, J. Madsen, D. Sachs.

  • Rejection of an Allograft Through Non-MHC Antigens Does Not Translate to the Rejection of a Different Allograft from the Same Donor in Mixed Chimeras

    K. Shinoda,1 C. Chase,1 P. Russell,1 J. Madsen,1 R. Colvin,2 A. Alessandrini.1

  • Rejection Triggers Liver Transplant Tolerance: Involvement of Mesenchyma-Meidated Immune Control Mechanisms

    M. Morita, D. Joyce, C. Miller, J. Fung, L. Lu, S. Qian.

  • Relations Among Hyperuricemia, Inflammation, Oxidative Stress and Arterial Stiffness in Renal Transplant Recipients

    B. Gurlek Demirci,1 S. Sezer,1 M. Erkmen Uyar,1 Z. Bal,1 E. Tutal,1 F. Ozdemir Acar,2 M. Haberal.3

  • Relationship Between Delayed Graft Function (DGF) Severity and Predicted DGF Risk

    E. Squiers,1 B. Irish,1 D. Odenheimer,1 S. Erlich,1 J. Grinyo, S. Feng, On Behalf of Quark DGF Study Investigators.

  • Relationship of Donor Age and Distance in Deceased Donor Lung Offers in the US

    L. Edwards,1 L. Robbins Callahan,1 W. Cherikh,1 J. Rogers,2 K. Chan.3

  • Relative In Vitro Immunoregulatory Effects of Everolimus, Sirolimus, Tacrolimus, Mycophenolic Acid and Drug Combinations

    J. Mathew, X. Huang, J. Leventhal, L. Gallon, J. Miller, J. Levitsky.

  • Remote Ischemic Perconditioning Induces Protection Against Hepatic Ischemia/Reperfusion Injury in Rats Via Downregualtion of Bax and Cleaved Caspase-3 Expression

    H. Ahn, M. Park, S. Joo, B. Kim.

  • Remote Ischemic Preconditioning Increases Transplantation of Abdominal Organs in Standard Criteria Neurological Death Donors

    A. Bongu,1 W. Washburn,2 J. Oliver,1 J. Nespral,3 A. Davidow,4 C. Kadric,3 G. Dikdan,1 J. Lewis,2 U. Pandit,1 A.-K. Beidas,1 C. Tourtellot,3 L. Brown,1 B. Koneru.1

  • Renal Allografts Demonstrate Improved Pathology After Belatacept Therapy

    T. Saavedra,1 O. Opara,1 R. McLoughlin,1 B. Philosophe,2 C. Drachenberg,1 M. Weir,1 S. Bartlett,1 D. Leeser,1 J. Bromberg,1 R. Barth.1

  • Renal Cell Carcinoma in the Native Kidney in Dialysis and Kidney Transplantation Recipients. Different Entities?

    K. Yamaçake, W. Nahas, H. Kanashiro, R. Kato, A. Bull, I. Antonopoulos, R. Falci, A. Piovesan.

  • Renal Dysfunction After Liver Transplantation in Recipients With Pre-Transplant Normal Renal Function

    S. Lee,2 J. Lee,1 M. Kim,1 B. Kim,3 D. Joo,1 G. Choi,1 J. Choi,1 S. Kim.1

  • Renal Dysfunction by BK Virus Infection Is Correlated With Activated T Cell Level, Cytokines Level, Gramzymes in Renal Transplantation

    W.-Y. Yin.

  • Renal Function Difference Between Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy and HBIG Combined With Entecavir in Liver Recipients

    J. Lee,1,2 J. Lee,1,2 J. Lee,3 M. Kim,1,2 M. Ju,1,2 G. Choi,1,2 J. Choi,1,2 S. Kim,1,2 D. Joo.1,2

  • Renal Function Following Basiliximab Induction in Liver Transplant Recipients

    J. Hagopian, T. Horwedel, L. Bowman, K. Collins, M. Doyle.

  • Renal Mass as a Determinant Factor of Long-Term Post-Donation Anemia

    S. Shah,1 B. Lankowsky,2 Z. Zaky,1 S. Nurko,1 R. Fatica,1 S. Gebreselassie,1 B. Stephany,1 E. Poggio.1

  • Renal Outcomes of Cross Match Positive Simultaneous Liver Kidney (SLK) Transplant Recipients Compared to Cross Match Positive Kidney Allograft Recipients

    S. Vaishnav,1 T. Taber,1 W. Goggins,2 S. Nagaraju,2 J. Fridell,2 A. Sharfuddin,1 M. Yaqub,1 D. Mishler,1 M. Mujtaba.1

  • Renal Resistance Measured During Pulsatile Perfusion and Long-Term Kidney Transplant Outcomes

    S. Sandal, R. Sapir-Pichhadze, M. Cantarovich, S. Paraskevas.

  • Renal Retransplantation in Simultaneous Pancreas Kidney Transplant Recipients

    W. Shields, J. Zimmerman, P. Mohan, F. Nooh, D. Hickey.

  • Renal Transplantation in Aged Over 60 Years Demonstrates Compatible Clinical Outcomes to Younger Recipients

    H. Cho,1 H. Kim,1 C. Baeck,1 H. Yu,1 D.-J. Han,2 M. Jo,3 S.-K. Park.1

  • Renal Tubular Dysfunction Following Donor Nephrectomy and Its Impact On Residual Kidney Function

    Z. Ahmed,1 C. Rooney,3 C. Turner,2 N. Dalton,2 N. Kessaris,1 N. Mamode.1

  • Renal Vein Elongation in Deceased Right Side Cadaveric Renal Grafts: Does It Increase the Risk of Thrombosis Or Hematoma Formation?

    J. Neves Neto, R. Soler, H. Marinho Neto, A. Ferreira, Jr., J. Offerni, S. Ximenes, J. Medina-Pestana, V. Ortiz, W. Aguiar, B. Leslie.

  • Repeat Donor HLA Mismatch Antigens and Kidney Transplant Outcome

    P. Lokhandwala,1 M. Wang,2 Z. Kadry,3 R. Shah,3 A. Jain,3 J. Gaspari,1 N. Ghahramani,4 C. Abendroth,1 H. Shike.1

  • Replacement of Lamivudine By Telbivudine to Improve Renal Function for Post-Transplant Hepatitis B Patients – A Randomized Clinical Trial

    W.-C. Lee, H.-S. Chou, R.-S. Soong, T.-J. Wu, C.-H. Cheng, Y.-C. Wang, T.-H. Wu, C.-F. Lee, K.-M. Chan.

  • Repurposing Jak/STAT Signaling Inhibition to Enhance Costimulation Blockade and Promote Transplant Acceptance

    G. Raimondi, S. Khalifian, D. Miller, B. Oh, G. Furtmueller, M. Fryer, W. Lee, G. Brandacher.

  • Resolution of Glomerular Fibrin Thrombi in Deceased Donor Kidneys

    R. Batra,1 M. Smith,3 L. Thomas,2 H. Khamash,2 A. Moss,2 J. Huskey,2 A. Singer,1 A. Mathur,1 N. Katariya,1 K. Reddy,1 R. Heilman.2

  • Respiratory Infections Following Lung Transplantation Leads to De Novo Development of Antibodies to Both Donor HLA and Lung Associated Self-Antigens and Increases the Risk for Bronchiolitis Obliterans Syndrome

    K. George,1 M. Gunasekaran,1 M. Sharma,1 F. Zhou,1 A. Limaye,3 R. Hachem,2 T. Mohanakumar.1

  • Responsiveness to Rituximab, Plasmapheresis and Intravenous Immunoglobulins in Antibody Mediated Rejections After Kidney and Pancreas – Kidney Transplantation

    E. Minué,1 L. León,1 P. Uva,1 A. Dotta,1 J. Walther,1 O. Casanova,1 F. Togniolo,1 O. Guardia,1 M. Rial,1 E. Chuluyan,2 D. Casadei.1

  • Results from the Use of Aortohepatic Conduit in Orthotopic Liver Transplantation: A Single Centre 12-Year Experience

    M. Aly, N. Chatzizacharias, A. Gimson, E. Huguet, A. Butler, C. Watson, G. Pettigrew, A. Jah, N. Jamieson, R. Praseedom.

  • Results of ABO Incompatible Liver Transplantation Using a Simplified Protocol at a Single Institution

    J. Lee,1 J. Lee,1 J. Lee,2 M. Kim,1 M. Ju,1 G. Choi,1 J. Choi,1 S. Kim,1 D. Joo.1

  • Results of Broader Sharing of Young Pediatric Donor Lungs and Priority Allocation System for Young Pediatric Lung Candidates

    W. Cherikh,1 A. Wilk,1 L. Edwards,1 G. Visner,2 Y. Cheng,1 S. Sweet.3

  • Retransplantation of the Elderly Diabetic: To Do Or Not to Do?

    A. Naik, A. Sakhuja, D. Cibrik, M. Samaniego.

  • Retrospective Cohort Study Concerning Efficacy and Safety of Bortezomib in Combination With Or Without Rituximab in Antibody Mediated Rejection in Renal Transplant Recipients

    M. Duerr, N. Lachmann, K. Budde, J. Waiser.

  • Return to Work and Occupational Infection Risks in Transplant Recipients

    R. Avery,1 D. Ostrander,1 S. Shoham,1 S. Alp,2 N. Lu,1 C. Cave,1 E. Kraus,3 K. Marr.1

  • Rewarming of Cold Preserved Livers Decreases Graft Injury and Kupffer Cell Activation by Normothermic Extracorporeal Liver Perfusion (NELP)

    B. Banan,1 R. Watson,2 Y. Lin,1 J. Jia,1 Z. Xiao,1 G. Upadhya,1 W. Chapman.1

  • Right-Sided Kidney Transplants Are Associated With Early Graft Failure in the Setting of Delayed Graft Function

    I. Hall, W. Jiang, S. Kulkarni, C. Parkih.

  • Rise in Deceased Donors Labeled "Increased Risk for Disease Transmission" Under New Guidelines

    L. Kucirka, M. Bowring, A. Massie, L. Nicholas, X. Luo, D. Segev.

  • Risk Associated With DCD Kidney Transplantation Varies by Donor Characteristics

    X. Luo, A. Massie, E. Chow, D. Segev.

  • Risk Factors for Acute Cellular Rejection for Pediatric Kidney Transplant Recipients

    D. Cote,1 I. Bobanga,1 B. Vogt,2 K. Dell,2 R. Cunningham III,2 K. Noon,1 V. Humphreville,1 E. Sanchez,1 J. Schulak,1 K. Woodside.1

  • Risk Factors for Graft Loss in Pediatric Renal Transplant Recipients After Transfer of Care

    B. Coyne,1,2 P. Hollen,1,2 Y. Guofen,3 K. Brayman.4

  • Risk Factors for Infections After Transplant in a Prospective Cohort Study Including Incompatible Kidney Transplant Recipients

    R. Avery,1 H.-L. Tsai,2 C.-Y. Huang,2 S. Shoham,1 D. Ostrander,1 N. Lu,1 R. Montgomery,3 K. Marr.1

  • Risk Factors Influencing Mammography Screening During Kidney Transplant Evaluation

    J. Stoecker, D. Cote, J. Augustine, N. Sarabu, J. Schulak, E. Sanchez, V. Humphreville, J. Ammori, K. Woodside.

  • Risk of Cause-Specific ESRD in Live Kidney Donors

    S. Anjum, A. Muzaale, A. Massie, S. Bae, D. Segev.

  • Risk of End-Stage Renal Disease After Living Donor Liver Transplantation: Overall Incidence and Comparisons to Deceased Donor Recipients

    D. Goldberg,1 R. Ruebner,2 P. Abt.3

  • Risk of ESRD Attributable to Live Kidney Donation in Various Subgroups of Donors

    A. Muzaale, A. Massie, D. Segev.

  • Risk of HLA Antibody Sensitization in Pediatric Heart Failure Patients Pre/Post Berlin VAD Procedure and Pre/Post Heart Transplantation

    R. Kerman, P. Jindra, A. Jeewa, S. Burki, C. Fraser, I. Adachi.

  • Risk of Post Liver Transplant (LT) Hepatocellular Carcinoma (HCC) Recurrence Is 2-Fold Higher in Women Compared to Men With AFP Levels at LT Between 101-500

    M. Sarkar,1 J. Dodge,2 F. Yao,1 J. Roberts,2 N. Terrault,1 N. Mehta.1

  • Risk Stratification in Tailoring Induction Therapy in Kidney Transplant Recipients(KTR): Is It Cost-Effective?

    B. Sirandas, A. Carlson, N. Kenyon, C. Truax, L. Smith.

  • Risks for Readmission Post-Renal Transplant: A Co-Morbid Condition

    M. John, A. Smith, I. Dortonne, A. Paramesh, M. Killackey, B. Lee, R. Zhang, J. Buell.

  • Rituximab With Intravenous Immune Globulin in Sensitized Patients Awaiting Heart Transplant: Does It Work?

    J. Patel, N. Reinsmoen, M. Kittleson, A. Velleca, D. Dilibero, F. Liou, D. Chang, A. Hage, L. Czer, F. Esmailian, J. Kobashigawa.

  • Rituximab: Summarizing the Intracacies of the Black Box Warning and Expenses in Transplantation

    N. Jandovitz, J. Lee, M. Bezman, D. Tsapepas.

  • Robotic Kidney Transplantation in Obese Recipients Can Lead to Superior Outcomes in Terms of Wound Infection and Graft Survival

    I. Tzvetanov, G. D'Amico, G. Georgiev, P. Giulianotti, H. Jeon, R. Garcia-Roca, J. Oberholzer, E. Benedetti.

  • Robotic Kidney Transplantation With Regional Hypothermia: Results from a Prospective Two-Arm Non-Randomized Controlled Trial (Ideal Phase 2b)

    R. Ahlawat,1 A. Sood,2 P. Ghosh,1 V. Kher,1 M. Bhandari,2 M. Menon.2

  • Role of CMV, BKV, and Immunosupression Non-Adherence in Early and Late De Novo Donor Specific Anti-HLA Antibody Development and Outcomes

    M. Everly,1 L. Rebellato,2 K. Briley,2 A. Maldonado,3 P. Bolin,2 C. Haisch,2 W. Kendrick,4 S. Kendrick,4 C. Morgan,2 R. Harland,2 P. Terasaki.1

  • Role of Complement in Mediating Pericyte Trans-Differentiation in Resident Myofibroblasts: A New Hypothesis On Vascular Rarefaction in Renal Ischemia/Reperfusion (I/R) Injury

    G. Castellano,1 R. Franzin,1 C. Divella,1 A. Stasi,1 A. Intini,1 M. Gigante,1 G. Lucarelli,1 P. Ditonno,1 M. Battaglia,1 A. Crovace,1 F. Staffieri,1 G. Pertosa,1 B. Oortwijn,2 E. Amersfoort,2 G. Grandaliano,3 L. Gesualdo.1

  • Role of Innate Immune Cells in Chronic Allograft Loss and Novel Strategies to Target Them

    C. Wu,1,2 P. Zhao,1 W. Liu,1 X. Xiao,1 X. Shi,1 Y. Peng,1 M. Kloc,1 X. He,2 M. Ghobrial,1 X. Li.1

  • Role of Universal Decolonization After Kidney Transplant: A Pilot Study

    D. Lee,1 G. Malat,2 N. Law,1 A. Sharma,1 T. Bias,1 K. Ranganna,1 A. Doyle.1

Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences